electroCore, Inc.
General ticker "ECOR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $55.7M (TTM average)
electroCore, Inc. follows the US Stock Market performance with the rate: 50.1%.
Estimated limits based on current volatility of 5.1%: low 7.76$, high 8.60$
Factors to consider:
- Total employees count: 83 (+13.7%) as of 2025
- US accounted for 93.9% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Regulatory and compliance, Funding reduction risk, Limited operating history, Strategic risks and growth management, Cybersecurity threats
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.73$, 7.52$]
- 2026-12-31 to 2027-12-31 estimated range: [2.39$, 6.68$]
Financial Metrics affecting the ECOR estimates:
- Negative: with PPE of -3.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Investing cash flow per share per price, % of 9.55 > 2.08
- Positive: Interest expense per share per price, % of 1.45 <= 2.54
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: Inventory ratio change, % of -1.26 <= -0.37
Short-term ECOR quotes
Long-term ECOR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $16.03MM | $25.18MM | $32.03MM |
| Operating Expenses | $35.30MM | $37.34MM | $45.19MM |
| Operating Income | $-19.27MM | $-12.16MM | $-13.15MM |
| Non-Operating Income | $0.25MM | $0.18MM | $-0.81MM |
| Interest Expense | $0.00MM | $0.39MM | $0.59MM |
| R&D Expense | $5.32MM | $2.36MM | $2.73MM |
| Income(Loss) | $-19.02MM | $-11.98MM | $-13.96MM |
| Taxes | $-0.19MM | $-0.09MM | $0.00MM |
| Net Income(Loss)* | $-18.83MM | $-11.89MM | $-13.97MM |
| Stockholders Equity | $7.44MM | $7.54MM | $-1.71MM |
| Inventory | $2.16MM | $1.68MM | $1.63MM |
| Assets | $16.10MM | $20.47MM | $18.67MM |
| Operating Cash Flow | $-14.67MM | $-6.95MM | $-8.19MM |
| Capital expenditure | $0.21MM | $0.00MM | $0.07MM |
| Investing Cash Flow | $-0.21MM | $-8.52MM | $3.88MM |
| Financing Cash Flow | $7.49MM | $8.44MM | $7.63MM |
| Earnings Per Share** | $-3.42 | $-1.59 | $-1.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.